RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Xuebiao Yao to Inhibitor of Apoptosis Proteins

This is a "connection" page, showing publications Xuebiao Yao has written about Inhibitor of Apoptosis Proteins.
Connection Strength

0.412
  1. Chu Y, Yao PY, Wang W, Wang D, Wang Z, Zhang L, Huang Y, Ke Y, Ding X, Yao X. Aurora B kinase activation requires survivin priming phosphorylation by PLK1. J Mol Cell Biol. 2011 Aug; 3(4):260-7.
    View in: PubMed
    Score: 0.378
  2. Fei Q, Zhang H, Fu L, Dai X, Gao B, Ni M, Ge C, Li J, Ding X, Ke Y, Yao X, Zhu J. Experimental cancer gene therapy by multiple anti-survivin hammerhead ribozymes. Acta Biochim Biophys Sin (Shanghai). 2008 Jun; 40(6):466-77.
    View in: PubMed
    Score: 0.020
  3. Song Z, Yao X, Wu M. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem. 2003 Jun 20; 278(25):23130-40.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support